Published in Retina on May 01, 2012
Outcomes of transconjunctival sutureless 27-gauge vitrectomy with silicone oil infusion. Graefes Arch Clin Exp Ophthalmol (2016) 0.95
Segmentation and removal of fibrovascular membranes with high-speed 23 G transconjunctival sutureless vitrectomy, in severe proliferative diabetic retinopathy. Clin Ophthalmol (2016) 0.75
Clinical outcomes of 23-gauge vitrectomy may be better than 20-gauge vitrectomy for retinal detachment repair. Mol Vis (2015) 0.75
Re: Sutureless 23-gauge versus 20-gauge vitrectomy with silicone oil injection in rhegmatogenous retinal detachment. Retina (2012) 0.75
Intravitreal silicone oil induced changes in corneal biomechanics. Int Ophthalmol (2013) 0.75
Understanding and using sensitivity, specificity and predictive values. Indian J Ophthalmol (2007) 3.05
Present status of eye care in India. Surv Ophthalmol (2004) 2.66
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci (2011) 2.53
An outbreak of acute post-cataract surgery Pseudomonas sp. endophthalmitis caused by contaminated hydrophilic intraocular lens solution. Ophthalmology (2012) 2.28
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol (2010) 1.82
Imaging pulsatile retinal blood flow in human eye. J Biomed Opt (2008) 1.73
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology (2013) 1.52
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol (2011) 1.46
Choroidal volume variations with age, axial length, and sex in healthy subjects: a three-dimensional analysis. Ophthalmology (2012) 1.46
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci (2011) 1.46
Endophthalmitis After Pars Plana Vitrectomy: Clinical Features, Risk Factors, and Management Outcomes. Asia Pac J Ophthalmol (Phila) (2016) 1.41
Role of frequency doubling technology perimetry in screening of diabetic retinopathy. Indian J Ophthalmol (2006) 1.39
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology (2012) 1.32
Variants in the 10q26 gene cluster (LOC387715 and HTRA1) exhibit enhanced risk of age-related macular degeneration along with CFH in Indian patients. Invest Ophthalmol Vis Sci (2008) 1.28
Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol (2007) 1.26
Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells. Retina (2006) 1.25
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology (2005) 1.22
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci (2006) 1.17
Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci (2006) 1.16
Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.15
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. Arch Ophthalmol (2009) 1.13
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology (2004) 1.13
Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome. J Ophthalmic Inflamm Infect (2013) 1.09
Ranibizumab. Nat Rev Drug Discov (2006) 1.08
Combined depth imaging technique on spectral-domain optical coherence tomography. Am J Ophthalmol (2012) 1.07
Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci (2005) 1.07
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology (2004) 1.07
Wet age-related macular degeneration. Adv Drug Deliv Rev (2005) 1.06
Uncertain compassion in using a drug before the risks and benefits are known. Arch Ophthalmol (2006) 1.05
Characterization of diabetic microaneurysms by simultaneous fluorescein angiography and spectral-domain optical coherence tomography. Am J Ophthalmol (2012) 1.05
Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol (2008) 1.02
Spontaneous bilateral peripapillary, subhyaloid and vitreous hemorrhage with severe anemia secondary to idiopathic thrombocytopenic purpura. Indian J Ophthalmol (2010) 1.02
Vancomycin-resistant Gram-positive bacterial endophthalmitis: epidemiology, treatment options, and outcomes. J Ophthalmic Inflamm Infect (2013) 0.98
Scleral buckle infections: microbiological spectrum and antimicrobial susceptibility. J Ophthalmic Inflamm Infect (2013) 0.97
Assessment of the differences in pharmacokinetics and pharmacodynamics between four distinct formulations of triamcinolone acetonide. Retina (2013) 0.97
Focal navigated laser photocoagulation in retinovascular disease: clinical results in initial case series. Retina (2012) 0.96
Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS One (2013) 0.96
Intravitreous dexamethasone effects on different patterns of diabetic macular edema. Arch Ophthalmol (2010) 0.95
Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina (2015) 0.95
SCLERAL BUCKLING WITH WIDE-ANGLED ENDOILLUMINATION AS A SURGICAL EDUCATIONAL TOOL. Retina (2016) 0.94
Endogenous endophthalmitis caused by Enterococcus casseliflavus. J Med Microbiol (2011) 0.94
High-resolution genotyping of Pseudomonas aeruginosa strains linked to acute post cataract surgery endophthalmitis outbreaks in India. Ann Clin Microbiol Antimicrob (2005) 0.93
Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant. Am J Ophthalmol (2003) 0.92
Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients. Clin Ophthalmol (2010) 0.92
Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema. Am J Ophthalmol (2013) 0.92
Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2. Retina (2012) 0.92
Microbiologic spectrum and susceptibility of isolates in acute postcataract surgery endophthalmitis: are they same as they were more than a decade ago? Br J Ophthalmol (2013) 0.91
The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 0.91
Mitochondrial DNA damage induced by 7-ketocholesterol in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci (2009) 0.90
Endophthalmitis after open globe injuries: changes in microbiological spectrum and isolate susceptibility patterns over 14 years. J Ophthalmic Inflamm Infect (2014) 0.90
Intraocular sustained-release delivery systems for triamcinolone acetonide. Pharm Res (2009) 0.90
Effects of Benzo(e)Pyrene, a toxic component of cigarette smoke, on human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci (2008) 0.89
Caspase-8, -12, and -3 activation by 7-ketocholesterol in retinal neurosensory cells. Invest Ophthalmol Vis Sci (2007) 0.89
Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin. J Ocul Pharmacol Ther (2013) 0.89
Multifocal electroretinography in type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol (2012) 0.89
Inadvertent intraocular injection of botulinum toxin A. J Pediatr Ophthalmol Strabismus (2011) 0.88
Development and evaluation of loop-mediated isothermal amplification assay for rapid and inexpensive detection of cytomegalovirus DNA in vitreous specimens from suspected cases of viral retinitis. J Clin Microbiol (2010) 0.87
Optical coherence tomography in progressive outer retinal necrosis. Ophthalmic Surg Lasers Imaging (2006) 0.86
Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology (2006) 0.85
The Implantable Miniature Telescope for macular degeneration. Curr Opin Ophthalmol (2006) 0.85
Systemic non-Hodgkin's lymphoma masquerading as Vogt-Koyanagi-Harada disease in an HIV-positive patient. Clin Experiment Ophthalmol (2006) 0.85
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Retina (2004) 0.85
Polymicrobial endophthalmitis: prevalence, causative organisms, and visual outcomes. J Ophthalmic Inflamm Infect (2013) 0.85
Activation of caspase-8 and caspase-12 pathways by 7-ketocholesterol in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2006) 0.85
7-Ketocholesterol activates caspases-3/7, -8, and -12 in human microvascular endothelial cells in vitro. Microvasc Res (2008) 0.85
Retinal adherence and fibrillary surface changes correlate with surgical difficulty of epiretinal membrane removal. Am J Ophthalmol (2011) 0.85
Complement factor H polymorphism in age-related macular degeneration. Ophthalmology (2007) 0.85
Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis. J Cataract Refract Surg (2010) 0.84
Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir. J Infect Dis (2004) 0.84
Restoration of retinal layers after epiretinal membrane peeling. Retina (2014) 0.84
Faster visual recovery after 23-gauge vitrectomy compared with 20-gauge vitrectomy. Retina (2010) 0.83
Temporal pattern of resolution/recurrence of choroidal neovascularization during bevacizumab therapy for wet age-related macular degeneration. Int J Ophthalmol (2013) 0.83
Comparative analysis of the retinal microvasculature visualized with fluorescein angiography and the retinal function imager. Am J Ophthalmol (2012) 0.83
CHOROIDAL VASCULARITY INDEX IN CENTRAL SEROUS CHORIORETINOPATHY. Retina (2016) 0.82
Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema. Retina (2014) 0.82
Spontaneous vitreous hemorrhage in children. Am J Ophthalmol (2013) 0.82
Differential effects of nicotine on retinal and vascular cells in vitro. Toxicology (2009) 0.82
Choroidal thickness profi le in healthy Indian subjects. Indian J Ophthalmol (2014) 0.82
A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. Invest Ophthalmol Vis Sci (2009) 0.81
Macular edema. General pathophysiology. Dev Ophthalmol (2010) 0.81
Pantoea agglomerans endophthalmitis: clinical features and outcomes. Retina (2014) 0.81
Inhibition of apoptosis in human retinal pigment epithelial cells treated with benzo(e)pyrene, a toxic component of cigarette smoke. Invest Ophthalmol Vis Sci (2009) 0.81
Drug delivery to the posterior segment of the eye. Eur J Ophthalmol (2011) 0.81
The effects of commercially available preservative-free FDA-approved triamcinolone (Triesence®) on retinal cells in culture. J Ocul Pharmacol Ther (2011) 0.80
Protective effects of memantine and epicatechin on catechol-induced toxicity on Müller cells in vitro. Toxicology (2010) 0.80
Vitreous hemorrhage in children and adolescents in India. J AAPOS (2013) 0.80
Vitreomacular disorders: pathogenesis and treatment. Retina (2012) 0.80
Toxicity of indocyanine green (ICG) in combination with light on retinal pigment epithelial cells and neurosensory retinal cells. Curr Eye Res (2005) 0.80